Skip to content
DraconiticResearch
Search Sources API
190,839 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BY 4.0mBio

The Story behind the Science: Solving the riddle for the pathogenesis of vulvovaginal candidiasis

  1. 1Department of Oral and Craniofacial Biology, School of Dentistry, LSU Health New Orleans, New Orleans, Louisiana, USA

Abstract

For nearly three decades, the pathogenesis of vulvovaginal candidiasis (VVC) remained an enigma. During the HIV/AIDS epidemic, observations that women with profound CD4+ T-cell deficiencies were not more susceptible to VVC challenged the prevailing assumption that protective adaptive immunity dictated all mucosal Candida infections. Here, we recount the scientific journey and trajectory that began with these observations and culminated in a paradigm shift in understanding VVC pathogenesis. Through extensive clinical studies, animal models, and a groundbreaking live Candida challenge clinical study, VVC was ultimately redefined as an immunopathogenic condition characterized by a robust yet dysfunctional neutrophil response to C. albicans within the vaginal environment. We highlight the key discoveries, challenges, and experiences that reshaped the field and finally solved the long-standing riddle of VVC pathogenesis.

Related

  1. Direct Cost Analysis of Diagnostic Pathways for Acute Vulvovaginal Candidiasis in Uganda: A Modeling Study
    Open forum infectious diseasesPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Chronic Hyperplastic Candidiasis on the Tongue in a 20-Year-Old Male: A Case Report
    Karthik Rajaram Mohan, Ramachandra Reddy Gowda Venkatesha
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Corticosteroids drive oral candidiasis by impairing type-17 immunity without inducing interferon-gammopathy
    Ashira Lubkin, Abigail Fellows, Lucas dos Santos Dias +2
    mBioPeer-reviewedPublisher termsFull textInfectious diseaseCrossref
  4. Genitourinary syndrome of lactation: An underrecognized postpartum condition affecting women’s vulvovaginal, urinary and sexual health
    Rodrigo Orozco Fernández, Santiago Palacios Gil-Antuñano
    Women's HealthPeer-reviewedCC BY-NC 4.0Full textPsychiatry & mental healthPMC
  5. Chrysin-loaded PCL nanocapsule spray as a topical strategy against cutaneous candidiasis
    Milena Luiza da Silva, Eric Luiz Domingos, Ahmad Kassem El Zein +4
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossrefEurope PMCEurope PMCPMC
BibTeX
@article{fidel2026story,
  title = {{The Story behind the Science: Solving the riddle for the pathogenesis of vulvovaginal candidiasis}},
  author = {Paul L. Fidel and Junko Yano},
  journal = {mBio},
  year = {2026},
  month = sep,
  doi = {10.1128/mbio.01787-26},
  url = {https://doi.org/10.1128/mbio.01787-26},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The Story behind the Science: Solving the riddle for the pathogenesis of vulvovaginal candidiasis
AU  - Paul L. Fidel
AU  - Junko Yano
PY  - 2026
DA  - 2026/09/14
JO  - mBio
DO  - 10.1128/mbio.01787-26
UR  - https://doi.org/10.1128/mbio.01787-26
AB  - For nearly three decades, the pathogenesis of vulvovaginal candidiasis (VVC) remained an enigma. During the HIV/AIDS epidemic, observations that women with profound CD4+ T-cell deficiencies were not more susceptible to VVC challenged the prevailing assumption that protective adaptive immunity dictated all mucosal Candida infections. Here, we recount the scientific journey and trajectory that began with these observations and culminated in a paradigm shift in understanding VVC pathogenesis. Through extensive clinical studies, animal models, and a groundbreaking live Candida challenge clinical study, VVC was ultimately redefined as an immunopathogenic condition characterized by a robust yet dysfunctional neutrophil response to C. albicans within the vaginal environment. We highlight the key discoveries, challenges, and experiences that reshaped the field and finally solved the long-standing riddle of VVC pathogenesis.
SN  - 2150-7511
ER  -